Evidence map›Paper›PMID 41069059›Full record

ArticleVirulence2025

Mucosal passive immunization with monoclonal antibodies targeting Candidalysin and Hyr proteins attenuates vaginal candidiasis in mice.

Julie Auffray, Nicolas Biteau, Anne Cayrel, Denis Dacheux, Hassana Hsein, Pierre Tchoreloff, Thierry Noel

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Virulence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Julie AuffrayUniversity Bordeaux, CNRS, Microbiologie Fondamentale Et Pathogénicité, UMR 5234, Bordeaux, France.
Nicolas BiteauUniversity Bordeaux, CNRS, Microbiologie Fondamentale Et Pathogénicité, UMR 5234, Bordeaux, France.
Anne CayrelUniversity Bordeaux, CNRS, Microbiologie Fondamentale Et Pathogénicité, UMR 5234, Bordeaux, France.
Denis DacheuxUniversity Bordeaux, CNRS, Microbiologie Fondamentale Et Pathogénicité, UMR 5234, Bordeaux, France.
Hassana HseinUniversity Bordeaux, CNRS, Bordeaux INP, Arts Et Metiers Institute of Technology, I2M Bordeaux, UMR 5295, Talence, France.
Pierre TchoreloffUniversity Bordeaux, CNRS, Bordeaux INP, Arts Et Metiers Institute of Technology, I2M Bordeaux, UMR 5295, Talence, France.
Thierry NoelUniversity Bordeaux, CNRS, Microbiologie Fondamentale Et Pathogénicité, UMR 5234, Bordeaux, France.ORCID 0000-0003-0320-1126

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vulvovaginal candidiasis (VVC) is a prevalent fungal infection primarily caused by the opportunistic pathogen

Indexed as

Antibodies, FungalAntibodies, MonoclonalCandida albicansCandidiasis, VulvovaginalFungal ProteinsImmunization, PassiveAnimalsDisease Models, AnimalFemaleImmunity, MucosalMiceMice, Inbred BALB CAntibodies, FungalAntibodies, MonoclonalFungal ProteinsCandida albicansCandidalysinHyr1monoclonal antibodypassive mucosal immunizationvulvovaginal candidiasis

Identifiers

PMID41069059
PMCPMC12520121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.